Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Biolog Announces Appointment of Distributors in Europe

Published: Thursday, September 27, 2012
Last Updated: Thursday, September 27, 2012
Bookmark and Share
New distributors to cover sales and marketing of Biolog’s innovative product lines.

New distributors were announced by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification of diverse cell types, from bacteria to human cells.

The distributors and their respective territories are IUL Instruments GmbH, Koningswinter, Germany (Germany and Austria), Awel International, Blain, France (France), A&LCO Industries, Cologno, Italy (Italy), and IUL S.A., Barcelona, Spain (Spain).

According to Barry Bochner, CEO & CSO at Biolog, "The distributors were selected as being most qualified to provide local supply, technical and service support to our customers in these countries."

Biolog's flagship product is the GEN III MicroPlate™, a test panel that can be used for identifying over 1,300 species of bacteria and covering human pathogens, animal pathogens, plant pathogens, and typical environmental bacteria.

Phenotype MicroArrays™, the company's most advanced product line, have diverse applications ranging from basic genetic and cellular research to cancer studies, drug and toxicology studies, and bioprocess optimization.

Biolog's product lines also include advanced instrumented systems such as the OmniLog® and MicroStation™ that automatically read and help to interpret the phenotypic data that is generated.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biolog’s PM Technology Unlocks Critical Clue in Understanding Autism
Discovery demonstrates advantage of metabolic over genetic screening.
Friday, June 07, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos